Company Neurocrine Biosciences, Inc. Sao Paulo
Equities
N1BI34
BRN1BIBDR009
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37 BRL | +8.00% |
|
+2.78% | +14.55% |
Business Summary
Number of employees: 1,448
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 1,489 | 100.0 % | 1,887 | 100.0 % | +26.76% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1,489 | 100.0 % | 1,887 | 100.0 % | +26.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Gorman
FOU | Founder | 66 | 01/92/01 |
Director of Finance/CFO | 44 | 01/17/01 | |
Jude Onyia
CTO | Chief Tech/Sci/R&D Officer | 60 | 30/21/30 |
Eiry Roberts
CTO | Chief Tech/Sci/R&D Officer | 60 | 08/18/08 |
Bill Wilson
COO | Chief Operating Officer | - | 01/96/01 |
Chief Tech/Sci/R&D Officer | 65 | 01/93/01 | |
Gary Lyons
BRD | Director/Board Member | 73 | 01/93/01 |
Todd Tushla
IRC | Investor Relations Contact | - | - |
Ingrid Delaet
LAW | General Counsel | 58 | 01/21/01 |
David Boyer
PRN | Corporate Officer/Principal | 44 | 30/19/30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01/99/01 |
George Morrow
BRD | Director/Board Member | 72 | 01/15/01 |
Kevin Gorman
FOU | Founder | 66 | 01/92/01 |
Christine Poon
BRD | Director/Board Member | 71 | 11/23/11 |
Chairman | 75 | 08/10/08 | |
Richard Pops
BRD | Director/Board Member | 62 | 01/98/01 |
Gary Lyons
BRD | Director/Board Member | 73 | 01/93/01 |
Leslie Norwalk
BRD | Director/Board Member | 58 | 01/98/01 |
Shalini Sharp
BRD | Director/Board Member | 49 | 03/20/03 |
Johanna Mercier
BRD | Director/Board Member | 54 | 15/21/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 100,637,227 | 98,821,809 ( 98.20 %) | 0 | 98.20 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
VOYAGER THERAPEUTICS, INC. 15.77% | 8,575,316 | 15.77% | 72,032,654 $ |
Company contact information
Neurocrine Biosciences, Inc.
6027 Edgewood Bend Court
92130, San Diego
+858 617 7600
http://www.neurocrine.com![address Neurocrine Biosciences, Inc.(N1BI34)](https://cdn.zonebourse.com/static/address/119084113.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+21.73% | 115B | |
+22.18% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+122.59% | 11.12B |
- Stock Market
- Equities
- NBIX Stock
- N1BI34 Stock
- Company Neurocrine Biosciences, Inc.